Sign in
4

Changes in Ownership

Dogwood Therapeutics, Inc. Filed Acc 0001415889-22-007085

Options or other derivatives

  • Director acquired 5,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
De La Rosa Abel Director 2022-06-23 Grant or award · Stock Option (right to buy) +5,250 5,250 D
Loading xslF345X03/form4-06302022_100643.xml…